Why Did CDXS Stock Jump 7% Today? The company tied up with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA using a proprietary ECO Synthesis platform.
Codexis Inc (NASDAQ:CDXS) Plummets After Q3 2025 Revenue and Earnings Miss Codexis stock plunges after Q3 2025 earnings miss estimates, with revenue of $8.6M falling far short of expectations.
What's going on in today's after hours session Discover the top movers in Thursday's after-hours session and stay informed about the post-market dynamics.
Curious about the stocks that are showing activity after the closing bell on Wednesday? After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Codexis Inc (NASDAQ:CDXS) Surpasses Q2 2025 Earnings Expectations with Strong Revenue and EPS Beat Codexis Inc (CDXS) beat Q2 2025 revenue and EPS estimates, driving a 6.89% after-hours stock surge. Strong enzyme engineering and RNAi therapeutic progress fuel optimism.
Get insights into the top gainers and losers of Wednesday's after-hours session. As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
